# DESCRIPTION

## FIELD OF INVENTION

- relate to therapeutics and prognostic markers in oncology

## BACKGROUND

- motivate molecular subtyping of muscle-invasive bladder cancer

## SUMMARY OF THE INVENTION

- introduce methods of detecting gene expression patterns
- describe detection of CDH12-high phenotype
- describe detection of CDH12-low phenotype
- describe detection of gene expression patterns in latent time
- provide methods of prognosis and treatment
- describe detection of gene mutations
- describe detection of gene expression patterns in tumor cells
- describe use of Gene Sets for detection and prognosis

## BRIEF DESCRIPTION OF THE GENE SETS

- describe Gene Set 1
- describe Gene Set 2
- describe Gene Set 3
- describe Gene Set 4
- describe Gene Set 5
- describe Gene Set 6
- describe Gene Set 7
- describe Gene Set 8
- describe Gene Set 9
- describe Gene Sets 10-34

## DESCRIPTION OF THE INVENTION

- define technical terms
- describe bladder anatomy and function
- explain bladder cancer and its stages
- define expression levels and cancer types
- describe study methodology and results
- summarize findings and implications

### Tumor Cell Phenotypes/Subgroups

- define tumor cell phenotypes
- describe intratumoral heterogeneity
- introduce CDH12 phenotype
- specify gene expression patterns
- contrast CDH12-high and CDH12-low phenotypes
- define CDH12-low phenotype
- define CDH12-high phenotype
- describe gene expression pattern of CDH12-low phenotype
- describe gene expression pattern of CDH12-high phenotype
- describe gene mutation pattern of CDH12-high phenotype
- describe gene mutation pattern of CDH12-low phenotype
- specify genes mutated in CDH12-high phenotype
- specify genes mutated in CDH12-low phenotype
- describe detection of CDH12-high phenotype
- describe detection of CDH12-low phenotype
- provide examples of gene mutations in CDH12-high phenotype
- provide examples of gene mutations in CDH12-low phenotype
- define KRT6A phenotype
- specify gene expression pattern
- provide variations of KRT6A-high phenotype
- define cycling phenotype
- specify gene expression pattern
- provide variations of cycling-high phenotype
- define UPK phenotype
- specify gene expression pattern
- provide variations of UPK-high phenotype
- define KRT phenotype
- specify gene expression pattern
- provide variations of KRT-high phenotype
- define tumor cell phenotypes
- describe CDH12-high phenotype
- describe CDH12-low phenotype
- introduce phenotype based on tumor cells' gene expression pattern
- describe latent time 0 gene expression pattern
- describe latent time 1 gene expression pattern
- specify genes in Gene Set 7
- specify genes in Gene Set 8
- describe gene expression pattern of latent time 0
- describe gene expression pattern of latent time 1
- provide examples of gene expression patterns
- summarize tumor phenotyping based on latent time
- define latent time 2 gene expression pattern
- define latent time 3 gene expression pattern
- define latent time 4 gene expression pattern
- describe applications of gene expression patterns
- introduce detection use of tumor phenotypes
- describe method for detecting CDH12-high phenotype
- describe method for detecting CDH12-low phenotype
- describe method for detecting KRT6A-high phenotype
- describe method for detecting cycling-high phenotype
- describe method for detecting UPK-high phenotype
- define tumor cell phenotypes
- describe KRT13-expressing and/or KRT17-expressing tumor cells
- describe gene expression patterns of latent times
- describe detection methods for gene expression patterns
- describe detection of CDH12+ tumor samples
- describe detection of gene expression or mutation patterns in CDH12-positive tumor samples
- describe detection of gene mutations in ERBB2, FGFR3, PAPPA2, ASAP1, OCA2, NDC80,
- describe association between gene expression and gene mutation
- describe detection of gene expression in subgroups of epithelial cells
- describe use of detected phenotypes for prognosis, therapy selection, or treatment
- describe detection techniques for gene expression and gene mutation patterns

### Reference Levels

- define reference levels

### Prognostic Uses

- motivate prognostic uses
- provide poorer survival prognosis
- provide poorer prognosis of responsiveness
- provide better survival prognosis
- provide better prognosis of responsiveness
- detect KRT-high phenotype
- detect UPK-high phenotype

### Treatment Methods

- define treatment methods for cancer
- administer neoadjuvant chemotherapy and/or surgery or radiation
- administer immune checkpoint inhibitor based on CDH12 expression
- administer TGFβ inhibitor, anti-angiogenic therapy, or combination
- treat CDH12-high phenotype with immune checkpoint inhibitor
- treat CDH12-low phenotype with chemotherapy
- administer anti-PDL1 or anti-PD1 therapy after neoadjuvant chemotherapy
- administer anti-TIM3 therapy after neoadjuvant chemotherapy
- perform treatment based on good survival prognosis or responsiveness
- detect CDH12-high phenotype and administer immune checkpoint inhibitor
- detect CDH12-low phenotype and administer chemotherapy
- provide examples of immune checkpoint inhibitors
- provide examples of neoadjuvant chemotherapy
- provide examples of TGFβ inhibitors
- provide examples of anti-angiogenic therapies
- formulate therapeutics for administration
- select patients for treatment based on CDH12 expression

### Kits/Systems

- define kits for detecting expression patterns
- list detection agents in kits
- describe additional detection agents in kits
- specify types of detection agents
- describe detection methods
- define systems for treating cancer
- list therapeutics in systems
- describe system for treating CDH12-high expression pattern
- introduce machine learning algorithm for gene selection
- describe gene selection method
- outline additional embodiments of the invention

## EXAMPLES

- provide illustrative examples

### Example 1). A CDH12+ Epithelial Cell Subpopulation in Bladder Tumors Responds Diametrically to Chemotherapy and Immunotherapy

- identify stem-like CDH12-expressing epithelial cells
- profile high-grade urothelial MIBCs using single-nucleus RNA-sequencing
- characterize intratumoral heterogeneity
- deconvolute current molecular subtypes into their normal constituent parts
- analyze epithelial compartment
- identify clusters with differential expression of KRT3 and KRT17
- annotate clusters using key marker genes
- observe substantial inter-tumoral heterogeneity in epithelial compositions
- analyze fibroblasts and immune compartment
- focus on deeper analysis of epithelial compartment
- verify expression of KRT13 and KRT17, and CDH12 and CDH18
- evaluate epithelial populations in context of previously published MIBC gene signatures
- analyze CDH12-enriched cells in healthy, normal bladder epithelium
- perform snSeq profiling on normal bladder samples
- identify CDH12 population as distinct node in path of bladder differentiation
- determine transcriptional similarity between CDH12 tumor cells and normal counterparts
- analyze predictive potential of differentiation path gene signatures
- predict poor prognosis in MIBC
- introduce CDH12+ epithelial cell subpopulation
- co-localize CDH12 cells with CD8 T-cells
- validate co-localization using CODEX platform
- define cellular niches with exhausted CD8 T-cells
- analyze CDH12 cells and CD8 T-cells in cellular niches
- identify CDH12-enriched cellular niches
- analyze CD8 T-cell phenotypes in CDH12-enriched niches
- discuss implications of CDH12 cells and CD8 T-cells
- introduce Cell-Cell Communication (C3) subpopulation
- discuss therapeutic relevance of C3 score
- describe materials and techniques
- outline research ethics
- detail tumor and normal sample preparation
- describe nuclei isolation and sequencing
- outline Visium sample preparation
- discuss public bulk RNA-seq datasets
- describe single-cell dimensionality reduction, clustering, and subtyping
- perform dimensionality reduction and cell type assignment
- identify marker genes for detailed subtyping
- derive gene sets specific to each cell subtype
- perform SCENIC Regulon Analysis and Gene Co-Expression Modules
- perform RNA Velocity and Tumor Nearest Normal Neighbor Identification
- perform Ligand-Receptor Interaction Analysis
- perform ssGSEA, Kaplan-Meier Analysis, and Differential Gene Expression for Bulk RNA-Seq
- perform Spatial Gene Signatures and Association with T-Cell Exhaustion Markers
- generate Visium field expression profiles
- test Visium spots for concurrent enrichment of expression profile scores and gene expression
- perform Immunohistochemistry
- describe data analysis workflow
- provide software and package versions used
- introduce CODEX protocol for tumor microarrays
- describe preparation of tumor microarrays
- outline staining and imaging protocol
- detail primary antibody screening and conjugation
- describe CODEX data pre-processing operations
- outline nuclear segmentation and feature extraction
- describe cell type identification using k-Nearest Neighbor classifier
- detail subtype classification and feature selection
- describe niche detection and spatial analysis
- outline cellular niche diversity and marker enrichment analysis
- describe code and data availability
- provide data availability information
- discuss various embodiments of the invention
- describe modifications and variations to the invention
- outline scope and limitations of the invention

### Gene Set 1

- list genes
- list genes
- list genes
- list genes
- list genes
- list genes

### Gene Set 2

- list genes

### Gene Set 3

- list genes

### Gene Set 4

- list genes
- list genes

### Gene Set 5

- list genes

### Gene Set 6

- list genes
- list genes
- list genes

### Gene Set 7

- list genes

### Gene Set 8

- list genes
- list genes
- list genes
- list genes
- list genes
- list genes
- list genes in Gene Set 8
- list genes in Gene Set 16
- list genes in Gene Set 17
- list genes in Gene Set 18
- conclude gene sets
- list genes in Gene Set 8
- list genes in Gene Set 19
- list genes in Gene Set 20
- list genes in Gene Set 21
- conclude gene sets
- list genes in Gene Set 8
- list genes in Gene Set 23
- list genes in Gene Set 24
- list genes in Gene Set 25
- list genes in Gene Set 26
- list genes in Gene Set 27
- list genes in Gene Set 28
- introduce gene sets
- define gene set 8
- define gene set 29
- define gene set 30
- define gene set 31
- define gene set 32
- define gene set 33
- define gene set 34

